Kearns-Sayre syndrome: Oncocytic transformation of choroid plexus epithelium

Journal of the Neurological Sciences

Volumn 178, Issue 1, 2000, Pages 29-36

  Tanji, Kurenai ^a   Schon, Eric A ^a   Dimauro, Salvatore ^a   Bonilla, Eduardo ^a  

^a Coll Phys Surgs of Columbia Univ ^*  (United States)

Author keywords

Choroid plexus; Kearns Sayre syndrome; Mitochondrial dysfunction

Indexed keywords

FOLIC ACID; LACTIC ACID; PYRUVIC ACID;

ADULT; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID EXAMINATION; CHOROID PLEXUS; CONTROLLED STUDY; ENCEPHALOMYOPATHY; EPITHELIUM; EPITHELIUM CELL; FEMALE; GENE DELETION; GENE DUPLICATION; GENE REARRANGEMENT; HEART BLOCK; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KEARNS SAYRE SYNDROME; MALE; MALIGNANT TRANSFORMATION; MUSCLE BIOPSY; OPHTHALMOPLEGIA; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; RETINOPATHY; SCHOOL CHILD;

ADOLESCENT; ADULT; CASE REPORT; CHOROID PLEXUS; DNA, MITOCHONDRIAL; EPITHELIUM; FATAL OUTCOME; FEMALE; HUMAN; IN SITU HYBRIDIZATION; KEARNS SYNDROME; MALE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034283541     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00354-3     Document Type: Article

References (49)

1. Berenberg R.A., Pellock S., DiMauro S., Schotland D.L., Bonilla E., Eastwood A., Hays A.P., Vicale C.T., Behrens M., Chutorian A., Rowland L.P. Lumping or splitting? "Ophthalmoplegia plus" or Kearns-Sayre syndrome? Ann. Neurol. 1:1977;37-54.
2. DiMauro S., Bonilla E. Mitochondrial encephalomyopathies. Rosenberg R.N., Prusier S.B., DiMauro S., Barchi R.L. The molecular and genetic basis of neurological disease. 1997;201-235 Butterworth-Heineman, Newton.
3. Macron J.M., Mizon J.P., Rosa A. Disorders of folate metabolism in the Kearns-Sayre syndrome. Rev. Neurol. (Paris). 139:1983;673-677.
4. Allen R.J., DiMauro S., Coulter D.L., Papadimitriou A., Rothenberg S.P. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann. Neurol. 13:1983;679-682.
5. Dougados M., Zittoun J., Laplane D., Castaigne P. Folate metabolism disorder in Kearns-Sayre syndrome. Ann. Neurol. 13:1983;687.
6. Okamato T., Riku S., Ibi T., Hukutomi K., Sonue I. Kearns-Sayre syndrome with reduced cerebrospinal fluid folic acid. Clin. Neurol. 25:1985;412-419.
7. Zeviani M., Moraes C.T., DiMauro S., Nakase H., Bonilla E., Schon E.A., Rowland L.P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology. 38:1988;1339-1346.
8. Schon E.A., Bonilla E., Miranda A.F., DiMauro S. Molecular biology of mitochondrial diseases. Brosius J., Fremeau R. Molecular genetic approaches to neuropsychiatric disease. 1991;57-80 Academic Press, San Diego.
9. Chen X., Prosser R., Simonetti S., Sadlock J., Jagiello G., Schon E.A. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet. 57:1995;239-247.
10. Schon E.A., Rizzuto R., Moraes C.T., Nakase H., Zeviani M., DiMauro S. A direct repeat is a hotspot for large-scale deletions of human mitochondrial DNA. Science. 244:1989;346-349.
11. Mita S., Rizzuto R., Moraes C.T., Shanske S., Arnando E., Fabrizi G.M., DiMauro S., Schon E.A. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucl. Acids Res. 18:1990;561-567.
12. Shanske S., Moraes C.T., Lombes A., Miranda A.F., Bonilla E., Lewis P., Whelan M.A., Ellsworth C.A., DiMauro S. Wide-spread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology. 40:1990;24-28.
13. Wallace D.C. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61:1992;1175-1212.
14. Schon E.A., Bonilla E., DiMauro S. Mitochondrial DNA mutations and pathogenesis. J. Bioenerg. Biomembr. 29:1997;131-149.
15. Tanji K., Vu T.H., Schon E.A., DiMauro S., Bonilla E. Kearns-Sayre syndrome: Unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann. Neurol. 45:1999;317-383.
16. Manfredi G., Vu T.H., Bonilla E., Schon E.A., DiMauro S., Arnaudo E., Zhang L., Rowland L.P., Hirano M. Association of myopathy with large-scale mitochondrial DNA duplications and deletions: Which is pathogenic? Ann. Neurol. 42:1997;180-188.
17. Chiu K.-P., Sullivan T., Bursztajn S. Improved in situ hybridization: color intensity enhancement procedure for the alkaline phosphatase/fast red system. BioTech. 20:1996;964-968.
18. Taanman J.-W., Burton M.D., Marusich M.F., Kennaway N.G., Capaldi R.A. Subunit specific monoclonal antibodies show different steady-state levels of various cytochrome c oxidase subunits in chronic external ophthalmoplegia. Biochem. Biophys. Acta. 1315:1996;199-207.
19. Mariottini P., Chomyn A., Attardi G., Trovato D., Strong D.D., Doolittle R.F. Antibodies against synthetic peptides reveal that the unidentified reading frame A6L, overlapping the ATPase 6 gene, is expressed in human mitochondria. Cell. 32:1983;1269-1277.
20. Gonzalez-Halphen D., Lindorfer M.A., Capaldi R.A. Subunit arrangement in beef heart complex III. Biochemistry. 27:1988;7021-7031.
21. Tanji K., DiMauro S., Bonilla E. Disconnection of cerebellar Purkinje cells in Kearns-Sayre syndrome. J. Neurol. Sci. 166:1999;64-70.
22. Schaffer D. Beitrage zur Histologie menschlicher Organe. 1897;[eit.Hampel 1931/9].
23. Hamperl H. Benign and malignant oncocytoma. Cancer. 15:1962;1019-1027.
24. Bauserman S.C., Hardman J.M., Schochet S.S., Earle K.M. Pituitary oncocytoma. Arch. Pathol. Lab. Med. 102:1978;456-459.
25. Silver M.M., Burns J.E., Sethi R.K., Rowe R.D. Oncocytic cardiomyopathy in an infant with oncocytosis in exocrine and endocrine glands. Hum. Pathol. 11:1980;589-605.
26. Müller-Höcker J., Aust D., Napiwotzky J., Münscher C., Link T.A., Seibel P., Schneeweiss S.G., Kadenbach B. Defects of the respiratory chain in oxyphil and chief cells of the normal parathyroid and in hyperfunction. Hum. Pathol. 27:1996;532-541.
27. Müller-Höcker J. Defects of the respiratory chain in hepatic oncocytes. Virchows Arch. 432:1998;349-356.
28. Baker L.B. A study of the parathyroid glands of the normal and hypophysectomized monkey (Macaca mulatta). Arch. Pathol. Lab. Med. 102:1942;456-459.
29. Roth S.I., Olen E., Hansen L.S. The eosinophilic cells of the parathyroid (oxyphil cells) salivary (oncocyte) and thyroid (Hurthle cells) glands. Lab. Invest. 11:1962;933-941.
30. McGavran M.H. The ultrastructure of papillary cystadenoma lymphomatosum of the parotid gland. Virchows Arch. [Pathol. Anat.]. 338:1965;195-202.
31. Müller-Höcker J., Jacob U., Seibel P. Hashimoto thyroiditis is associated with defects of cytochrome c oxidase in oxyphil Askanazy cells and with the common deletion (4977) of mitochondrial DNA. Ultrastruct. Pathol. 22:1998;91-100.
32. Kepes J.J. Oncocytic transformation of choroid plexus epithelium. Acta Neuropathol. 62:1983;145-148.
33. Ohama E., Ikuta F. Involvement of choroid plexus in mitochondrial encephalomyopathy (MELAS). Acta Neuropathol. 75:1987;1-7.
34. Bonilla E., Sciacco M., Tanji K., Sparaco M., Petruzzella V., Moraes C.T. New morphological approaches for the study of mitochondrial encephalopathies. Brain Pathol. 2:1992;113-119.
35. Sciacco M., Bonilla E., Schon E.A., DiMauro S., Moraes C.T. Distribution of deleted and wild-type mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum. Mol. Genet. 3:1994;13-19.
36. Nakase H., Moraes C T., Rizzuto R., Lombes A., DiMauro S., Schon E.A. Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am. J. Hum. Genet. 46:1990;418-427.
37. Hayashi J.-I., Ohta S., Kikuchi A., Takemitsu M., Goto Y.I., Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA. 88:1991;10614-10618.
38. Wallace D.C. Mitochondrial DNA mutations and neuromuscular disease. Trends Genet. 5:1989;9-13.
39. Spector R., Johanson C.E. The mammalian choroid plexus. Sci. Am. 260:1986;68-74.
40. Fishman R.A. Physiology of the cerebrospial fluid. Fishman R.A. Cerebrospinal fluid in disease of the nervous system. 1992;23-42 Saunders, Philadelphia.
41. Prockop L.D., Fishman R.A. Experimental pneumococcal meningitis: permeability changes influencing the concentraion of sugars and macromolecules in cerebrospinal fluid. Arch Neurol. 19:1968;449-463.
42. Coulter D.L., Allen R.J., DiMauro S., Rothenberg S.P. Kearns-Sayre syndrome: a possible disorder of folate metabolism. Ann. Neurol. 8:1980;222.
43. Spector R. The effects of pronase on choroid plexus transport. Brain Res. 134:1977;573-576.
44. Spector R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53:1989;1667-1674.
45. Daroff R.B., Solitare G.B., Pincus J.H., Glaser G.H. Spongiform encephalopathy with chronic progressive external ophthalmoplegia. Neurology. 16:1966;160-169.
46. Bonilla E., Tanji K., DiMauro S., Schon E.A. Neurologic and neuropathologic features of mitochondrial encephalomyopathies. Beal M.F., Bodis-Wollner I., Howell N. Neurodegenerative diseases: Mitochondria and free radicals in pathogenesis. 1997;271-279 John Wiley & Sons, New York.
47. Levitt M., Nixon P.F., Pincus J.H., Bertino J.R. Transport characteristics of folates in cerebrospinal fluid, a study utilizing doubly labelled 5-methyl tetrahydrofolate and 5-formyl terahydrofolate. J. Clin. Invest. 30:1971;1301-1308.
48. Hirata F., Axelrod J. Phospholipid methylation and biological signal transmission. Science. 209:1980;1082-1090.
49. Korevaar W.C., Geyer A., Knapp S. Regional distribution of 5-methyl terathydrofolic acid in brain. Nature New Biol. 245:1973;244-245.